Stay updated on IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial
Sign up to get notified when there's something new on the IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial page.

Latest updates to the IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check30 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
- Check45 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check66 days agoChange DetectedThe intervention type has been updated to 'Verified 2022-09 by Innovent Biologics (Suzhou) Co. Ltd.' with the last known status as 'Recruiting', reflecting a revision from v2.13.3 to v2.14.0.SummaryDifference3%
- Check95 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI110 Safety and Efficacy in Advanced Tumors Clinical Trial page.